Bladder Inflammatory Response to Tachykinins
Author Information
Author(s): Saban Ricardo, Simpson Cindy, Vadigepalli Rajanikanth, Memet Sylvie, Dozmorov Igor, Saban Marcia R
Primary Institution: The University Oklahoma Health Sciences Center
Hypothesis
What transcriptional regulatory elements can be therapeutically targeted to reduce the influence of tachykinins in bladder disorders?
Conclusion
This study identifies Nkx2.5 as a unique discriminator in NK1R-modulated inflammation in the urinary tract, suggesting potential new therapies targeting Nkx2.5 activity.
Supporting Evidence
- NK1R-dependent genes were identified through cDNA array analysis.
- Nxk2.5 was found to be significantly correlated with multiple transcripts involved in bladder inflammation.
- Electrophoretic mobility shift assays confirmed the activation of Nkx-2.5 and NF-kappaB in response to substance P.
Takeaway
The study looks at how certain proteins in the bladder respond to a substance called tachykinin, which is involved in inflammation. It finds a specific protein, Nkx2.5, that could be important for treating bladder problems.
Methodology
The study used cDNA array analysis and in silico analysis of transcription regulatory elements in mouse models to identify NK1R-dependent genes and their regulatory networks.
Limitations
The study primarily uses animal models, which may not fully replicate human bladder disorders.
Participant Demographics
Female mice aged ten to twelve weeks were used in the experiments.
Statistical Information
P-Value
0.01 < p < 0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website